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AbstrACt
Introduction Hospital group models represent an 
organisational form that aims to bring together multiple 
provider organisations with a central headquarters 
and unified leadership responsible for locally managed 
operating units, standardised systems and a value-set 
shared across the group. These models seek to improve 
outcomes by reducing unwarranted variations in care 
provision and reducing costs through economies of scale. 
There is limited evidence on the impact and processes of 
implementing these models, so this study aims to evaluate 
one case study of a hospital group model.
Methods and analysis We will conduct a formative, 
mixed-methods evaluation using an embedded research 
approach to analyse the implementation of the model 
and its impact on outcomes and costs. We will carry out a 
multisited ethnography to analyse the programme theory 
for model design and implementation, the barriers and 
facilitators in the implementation; and wider contextual 
issues that influence implementation using semi-
structured interviews (n=80), non-participant observations 
(n=80 hours), ‘shadowing’ (n=20 hours) and documentary 
analysis. We will also carry out an economic evaluation 
composed of a cost-consequence analysis and a return on 
investment analysis to evaluate the costs of creating and 
running the model and balance these against the potential 
cost-savings.
Ethics and dissemination The study protocol was 
reviewed by the local R&D Office and University College 
London Ethics Committee and classified as a service 
evaluation, not requiring approval by a research ethics 
committee. We will follow guidelines for informed consent, 
confidentiality and information governance, and address 
issues of critical distance prevalent in embedded research. 
Findings will be shared at regular time points to inform 
the implementation of the model. The evaluation will also 
generate: an evaluation framework to evaluate future 
changes; recommendations for meaningful baseline 
data and measuring improvement; identification of 
implementation costs and potential cost-savings; and 
lessons for the National Health Service on implementing 
these models.
IntroduCtIon
Several countries are currently implementing 
models of healthcare delivery that rely on 
joint-working arrangements between multiple 
healthcare providers in the form of hospital 
groups or chains.1 In England, the Five Year 
Forward View sets out a future strategy for 
the National Health Service (NHS) through 
the implementation of new care models.2 A 
review of new organisational models for deliv-
ering care in the NHS also presented models 
through which providers could develop 
formal arrangements to collaborate and 
work at scale,3 thereby improving outcomes 
by reducing unwarranted variations in care 
provision and reducing costs through econ-
omies of scale. A ‘hospital group’ has been 
defined as an organisational model that brings 
together multiple provider organisations and 
has the following characteristics: (1) a central 
headquarters responsible for unified leader-
ship; (2) locally managed operating units; (3) 
standardised systems, practices and protocols; 
and (4) a culture and value-set that is shared 
across the group.3–5 Four group models have 
strengths and limitations of the study:
 ► The embedded approach aims to facilitate the 
co-design of the study with research users and reg-
ular sharing of evaluation findings while maintaining 
a critical distance.
 ► The multisited ethnography will enable the explora-
tion of implementation processes and experiences 
of the model from the perspectives of a wide range 
of stakeholders and multiple participating sites.
 ► The economic component of the evaluation will 
compare the group model with non-group model 
comparators, allowing for broader lessons for the 
National Health Service.
 ► This is an evaluation of one hospital group model, 
thus limiting the generalisability of the findings.
 ► The evaluation is dependent on the implementation 
of the group model within the study time  frame, 
which creates a risk for the study if there are im-
plementation delays or if the  implementation does 
not occur.
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been accredited by NHS Improvement. These hospital 
groups have acquired distinct organisational models and 
legal forms4 (table 1).
A case study of a group model
This evaluation focuses on one case study of a hospital 
group model (type 4, model with different types of 
membership and organisational sovereignty listed in 
table 1). The aim of this organisational form is to intro-
duce new ways of operating across a group of providers. 
Providers can join the group as full members (losing sover-
eignty to the group headquarters) or clinical partners 
(maintaining sovereignty and selecting which group 
model services to participate in). The case study we are 
evaluating includes one full member organisation formed 
in a merger of two organisations in 2014 (three hospital 
sites in total), and two clinical partners (one organisation 
with one hospital site and another with three hospital 
sites). Anticipated benefits of the implementation of 
this group model are: (1) improve clinical outcomes 
and increase patient safety and satisfaction by reducing 
unwarranted variations in care, (2) improve staff expe-
rience through career development opportunities and 
(3) reduce unit and system costs by streamlining wasteful 
processes and through economies of scale.6 To achieve 
this, the group aims to standardise clinical and non-clin-
ical processes, consolidate clinical, clinical support and 
non-clinical services, and develop processes to promote 
leadership and workforce development (table 2).6
Group members will be connected through common 
processes, governance and back-office systems, led by a 
group headquarters. The group model structure will 
comprise a series of hospital units which will report 
to a Hospital Group Board. Clinical Working Groups 
(CWGs) will work across all hospital units. Each CWG 
contains a number of pathways that will be redesigned 
and standardised across relevant hospital units to elim-
inate unwarranted variation in care. Shared services, in 
the form of clinical support (eg, radiology and pharmacy) 
and non-clinical services (eg, finance and HR), will be 
centralised and provide support to all hospital units with 
full or clinical partner membership.
overall approach to the study
We will use an embedded research approach,7 8 where 
researchers who have dual affiliation (to an academic 
institution and a healthcare organisation) are ‘embedded’ 
within the organisation(s) and co-produce knowledge 
with local staff that responds to the needs of the organ-
isation and helps build research capacity.7 The prin-
ciple of co-production is a core element of embedded 
research and it is based on the premise that researchers 
and members of staff from various layers and areas of 
the organisation can all provide different types of useful 
knowledge and expertise.7 In the case of this evaluation, 
we will collaborate closely with staff and managers from 
the healthcare organisations, to co-design and conduct 
research on identified needs, and share formative feed-
back at regular intervals. The embedded approach will 
also allow us to adapt rapidly to changes in context and 
make modifications in the study design, as appropriate 
while maintaining the independence of the research.
Table 1 Types of hospital group models in England
Model Description Legal form
1. Federation Organisations come together to collaborate 
on areas of mutual interest, after agreeing 
on a set of common standards. Each 
organisation retains its sovereignty
Agreement can be set out in a legal 
contract or memorandum of understanding
2. Delegated authority Organisations agree to delegate some or all 
decision-making to a single organisation. 
Each organisation retains its sovereignty and 
the decision-making body is accountable to 
the Boards of each organisation
Trusts can set-up their own committees 
(with the same remit and membership), 
which can be supported by a legally 
binding contractual joint venture between 
the providers
3. Management responsibility One organisation takes management 
responsibility for another. Each organisation 
retains its Board, but the host organisation 
is accountable for the performance of 
organisations under its management
The host organisation enters into a 
management contract with another 
organisation for an agreed period of time
4. Wholly owned subsidiaries/
model with different types of 
membership and organisational 
sovereignty
The group is a single sovereign entity 
with discrete ‘operating units’. The group 
has a single Board, accountable for the 
performance of all organisations within the 
group. Some organisations might join the 
group under different types of membership 
and organisational sovereignty
The legal form is a single NHS Foundation 
Trust (with additional organisations joining 
as members under different partnership 
categories)
Source, Based on NHS Group Models developed by Credo Business Consulting.4
NHS, National Health Service.
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The study protocol was co-produced and the selection 
of areas to be included in the evaluation was informed 
by:
 ► Early engagement with teams in the lead healthcare 
organisation in 2016.
 ► Meetings with teams in the lead healthcare organisa-
tion to discuss developments in group priorities and 
participate in a bidders’ event (June to September 
2017).
 ► Scoping exercise and prioritisation workshop to prior-
itise areas for the evaluation (October to November 
2017).
research questions
The evaluation will address the following research 
questions:
1. What is the programme theory underpinning the 
group model and how does it develop over time?
2. What are the processes used to implement organisa-
tional change across the group and how do these de-
velop over time?
3. What are the barriers and facilitators encountered in 
the implementation of the group model? What is the 
impact of wider contextual factors?
4. What quantifiable impacts, costs, potential benefits 
and cost-savings, if any, does the group model have 
within different contexts?
5. What are the lessons for implementing models of this 
kind?
MEthods And AnAlysIs
design
The study will use a mixed-methods design, combining 
multisited ethnographic research with a health economics 
evaluation to evaluate a case study of a hospital group 
model.
The evaluation will focus on five main areas of the 
hospital group model (table 3). These areas will be used 
as ‘tracer issues’.9 The evaluation will trace the activities 
of pathway teams within two Clinical Working Groups, 
including an analysis of specific tasks, processes for 
establishing evidence-based standards and measurement 
processes; engagement with the new e-platform (digi-
tisation), and interaction between different organisa-
tions within the group structure. It will also look at how 
approaches to implementing the new structure might 
enable or hinder implementation success (identified as 
the capacity of the group model to achieve its goals of 
standardisation and consolidation). The evaluation will 
examine the development of the quality improvement 
and leadership development programmes (eg, main activ-
ities, staff perceptions and use of the programmes, poten-
tial impact of the programmes) across the hospital group. 
The study will also analyse the consolidation of clinical 
support services (pharmacy) and non-clinical services 
(finance). The evaluation will analyse the original plans 
behind the design of the hospital group model and how 
these have changed through time. An important compo-
nent of the evaluation will be capturing the experiences of 
Table 2 Objectives, processes and expected outcomes of the hospital group model
Objective Process Outcome
1. Reduce unwarranted variation in 
clinical and non-clinical processes
 ► Implement evidence-based standard 
clinical processes
 ► Standardise approach to non-clinical 
processes
 ► Improve clinical outcomes and reduce 
unit and system-wide cost
 ► Deliver cost savings and free up 
clinician time
2. Consolidate clinical and non-clinical 
activity by centralising and removing 
duplication of services
 ► Centralise non-clinical activity
 ► Consolidate clinical support services 
across the group
 ► Consolidate clinical services to drive 
quality and value
 ► Improve quality and reduce cost
 ► Generate economies of scale, improve 
the use of specialist resources 
and improve service quality
 ► Improve quality, effectiveness and 
reduce the cost of delivery (eg, by 
reducing the duplication of services 
across organisations)
3. Use leadership and expertise to drive 
quality improvement
 ► Invest in leadership capabilities and 
workforce development
 ► Promote the better use of resources 
across the group
 ► Effective performance management of 
members
 ► Staff with skills and expertise to deliver 
transformation
 ► Improve use of resources across 
the group using increase scale
 ► Improve performance and enable 
the delivery of transformation
4. Deliver system-wide benefits through 
whole pathway re-design
 ► Collaborate with local healthcare 
providers
 ► Reduce admissions to secondary 
care, and thereby reduce total system 
costs; improve patient outcomes and 
satisfaction
Source: Greyed out row (deliver system-wide benefits through whole pathway re-design) is outside scope of this evaluation as changes will 
not be implemented within the time scale of the evaluation.
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the local units who are part of the group, from the initial 
stages of joining the group through full implementation 
(as allowed by the study time frame).
Implementation study of the group model
We will carry out an organisational study of the imple-
mentation of this group programme using a multisited 
ethnographic approach. Multisited ethnographies allow 
researchers to capture different views, interactions 
and communication across a wide range of contexts.10 
Adopting characteristics of a more ‘mobile ethnog-
raphy’,11 multisited ethnographies facilitate the iden-
tification of changes in processes across physical spaces 
(ie, different healthcare environments) and conceptual 
spaces (ie, clinical pathways).
This component of the evaluation aims to use 
embedded research to understand how the group model 
is being governed and implemented in real time and how 
it changes over time, to facilitate more effective imple-
mentation, identify lessons for enabling improvement 
and inform the health economic component of the study. 
We will explore three main dimensions of the implemen-
tation of the group programme: (1) changes in organ-
isational structures (eg, Boards, committees and local 
hospital units), (2) changes in service organisation and 
delivery and (3) quality improvement and leadership 
development. This will involve studying (a) the devel-
opment and implementation of the new organisational 
structures, processes and cultures associated with the 
group model and (b) gathering stakeholders’ (including 
clinical, non-clinical and management staff from across 
sites) perceptions of the group model and processes of 
implementing change within the healthcare organisa-
tions, including staff members’ views on their engage-
ment with the model.
Economic evaluation
We will investigate the costs, the potential cost savings, 
and the potential benefits of implementation of the 
hospital group model.
We expect the implementation of the group model to 
produce set-up costs and additional running costs. The 
set-up costs are likely to include direct and/or opportunity 
costs related to staff (training and change in staff-patient 
ratio) and capital (cost of digitisation, cost of IT system 
upgrade and so on), whereas the additional running costs 
are likely to refer to increased administrative workload 
(eg, additional group meetings, board meetings and 
so on). Benefits and impacts will be measured consis-
tently with the process evaluation (processes defined 
in table 2). As the outputs from these consist mostly of 
process measures, a meaningful quantitative ranking will 
be derived from the qualitative ethnographic findings.
One important issue is the perspective of the analysis—
the institutional viewpoint to take when measuring costs, 
cost-savings and benefits. From a health economics point 
of view, three separate and relevant perspectives exist: (1) 
the Hospital Group; (2) full members or clinical part-
ners and (3) CWGs running across partners. The most 
relevant perspective for the evaluation should be jointly 
decided with local teams, following the same principle of 
co-production already outlined above.
Table 3 Main areas included in the evaluation
Programme/Project area* Sub-areas† Site coverage Implementation timeline
1. Group operating model Governance All organisations currently 
within the group and new 
organisations joining the group
Started planning the group 
model with three existing sites 
in August 2017, with additional 
sites joining as clinical partners
2. Two pathways within two 
CWGs
Two pathways (within each 
CWG):
1. Induction of labour (Women 
and Children’s CWG)
2. Heart failure (Medicine and 
Urgent Care CWG)
All organisations currently 
within the group and new 
organisations joining the group 
(pathways cover all sites)
Piloting of pathways started 
in January 2018. Induction of 
labour has implemented the 
changes in two organisations. 
Heart failure is still in 
the piloting stage
3. Corporate Support Services Finance All organisations currently 
within the group and new 
organisations joining the group
Implementation date to be 
determined
4. Leadership and Workforce 
capability
Leadership development
QI
All organisations currently 
within the group and new 
organisations joining the group
Implementation started in 2017
5. Group Clinical Services Pharmacy One organisation which 
merged in 2014 (comprising 
three hospitals) and new 
organisations joining the group
Implementation in April 2019
*Processes of joining the group will be captured in all areas.
†Staff experience impacts will be explored qualitatively in all areas.
CWG, Clinical Working Group; QI, quality improvement. 
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Based on the priorities identified by local staff in 
interviews from the scoping phase of the evaluation and 
documentary analysis, we are proposing two economic 
approaches. The first is a cost-consequence analysis (CCA). 
A CCA is a form of economic evaluation comparing alter-
native interventions in which the components of incre-
mental costs (direct or indirect) and consequences (eg, 
knowledge, behaviours and processes) are computed and 
listed, without aggregating these results into a cost-effec-
tiveness ratio. The CCA has been previously described 
as distinct from both cost-effectiveness analysis (CEA) 
and cost-benefit analysis (CBA).12 13 This approach was 
selected as it enables producing quantifiable results from 
process measures and other findings traditionally evalu-
ated qualitatively, such as quality improvement (QI). The 
CCA will rely on emerging findings from the organisa-
tional study in order to define quantifiable consequence 
parameters, such as the degree of standardisation of 
pathways or number of leaders trained within the group 
model.
The second economic approach is a return on investment 
(ROI) study. This will allow for the costs of the model to 
be balanced against potential cost-savings that relate to 
the decrease in unwarranted variation (CWGs: two path-
ways). This second component of the economic evalua-
tion will be carried out in addition to the CCA within the 
30-month time scale (see table 4). Unlike the CCA, the 
ROI analysis does not depend or rely on the qualitative 
organisational study.
Both the CCA and ROI analysis will take an incre-
mental approach, which implies defining a counterfac-
tual or a comparator, which could be another hospital 
group or the extrapolation of the performance of each 
site composing the group model before they joined the 
group. The comparator ought to be jointly defined with 
the hospital group stakeholders via the formative feed-
back process established by the embedded research team.
Although ideally the same areas covered in the organ-
isational component of this study would be evaluated in 
economic terms, due to implementation delays or data 
unavailability, the economic evaluation will focus on 
the Group operating model and the two pathways of 
the clinical practice groups as originally planned. Using 
the embedded approach as an opportunity for research 
capacity development, it was agreed between the research 
team and group stakeholders that area of Leadership and 
Workforce capability would produce a CCA framework, to 
be carried out at a later stage after this research.
data collection
Implementation study of the group model
Data collection will be carried out through semi-structured 
interviews, non-participant observation and documentary 
analysis. Following a multisited approach, researchers will 
consider data collection as a mobile process, entailing 
physical presence in multiple organisations and concep-
tual analysis of various social spaces.14 In order to ensure 
the depth and richness of data despite the breadth of 
organisational coverage, we will use a ‘focused ethnog-
raphy’ approach, which is based on targeted fieldwork in 
a series of locations over short periods of time.14
We will analyse the experiences of local sites by docu-
menting processes of joining the group and different 
stages of implementation of the programmes of the 
group model. Data collection will focus on the three 
dimensions outlined above (changes in organisational 
structures and cultures, service organisation and delivery, 
and leadership development and quality improvement). 
Semi-structured interviews will be conducted at multiple 
organisational levels within the group structure and also 
capture the perceptions of member Trusts and other local 
and external stakeholders (table 5). Repeat interviews will 
be carried out with a sub-section of those interviewed in 
round 1 to enable a longitudinal analysis of programme 
implementation. Topic guides will be used to guide the 
interviews and the interviews will be audio recorded.
Following the tracer issues (table 3), the evaluation 
team will observe relevant planning and implementa-
tion meetings at group level (eg, Hospital Group Board 
meetings), CWG level (eg, CWG implementation group 
meetings), at the level of hospital units (eg, Board meet-
ings), divisions (eg, committee meetings) and clinical 
team level (eg, pathway team meetings). We will aim to 
shadow the pathway leads to understand how their daily 
activity spans multiple organisations (up to 20 hours). 
We will aim to observe training sessions from the QI and 
leadership development programmes and related lead-
ership events. We will also observe project management 
meetings (covering the same levels) used to plan the 
implementation of the consolidation of clinical support 
and non-clinical services. The observations will be docu-
mented in the form of field notes.
Documents from the various areas included in the eval-
uation will also be collected. These will include reports, 
planning documents and minutes from the meetings 
outlined above. These will be collected from the area 
leads and meeting Chairs. A document inventory will be 
used to catalogue the documents.
Economic evaluation
For the CCA analysis, two types of cost data will be 
required. First, outgoings and investments, both in 
terms of setting up the group model and running it on 
Table 4 Economic approach chosen for each component 
of the evaluation
Programme/Project area Economic approach
Group operating model CCA
Clinical Practice Groups 
(CWGs)
CCA and ROI
Leadership and Workforce 
Capability
CCA framework
CCA, cost-consequence analysis; CWG, Clinical Working 
Group.; ROI, return on investment. 
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a day-to-day basis, in the areas selected for evaluation by 
organisations within the group will be obtained via docu-
mentary analysis. Second, data on time spent on each 
activity directly observed by the research team, including 
collaboration meetings, workshops and trainings, will be 
collected. For non-observed activities, an estimate of time 
and participating staff will be requested from the hospital 
group, in order to include staff opportunity time costs. 
The translation of time costs into monetary costs could be 
based on the Unit Costs for Health and Social Care, from 
the Personal Social Services Research Unit (PSSRU), or 
alternatively one could use the actual hourly costs of staff, 
should this information be available to the research team.
For the ROI analysis, we will require data on the volume 
and costs of corporate support and group-clinical services. 
For the selected CWG pathways, we will require data on 
length of stay, unexpected hospital admissions, unex-
pected intensive care unit (or neonatal intensive care 
unit) admissions, waste of materials, unnecessary use of 
medication/drugs and unnecessary surgical procedures 
(eg, non-emergency caesarean sections) covering 6–12 
months before and 6–12 months after the transformation 
into the group model. For both selected CWG pathways, 
we will also require the total volume of activity, as well 
as the proportion of patients who are low and high risk, 
and those who end up having complications (by compli-
cation type). Data on the distribution of patients along 
the pathway is paramount for the ROI to be consistent 
and meaningful. The embedded research team will 
provide formative feedback to increase the likelihood 
of measuring the required data consistently across all 
group members. Should these data be unavailable for 
a full return on investment analysis, we will perform a 
simpler prospective analysis, using cost-savings parame-
ters obtained in a literature review. This type of analysis 
would highlight the potential for cost-savings.
sampling framework
Implementation study of the group model
We will sample staff members using the vertical slice 
technique,15 16 whereby staff members representing 
different layers, sites and sectors of the organisation are 
sampled purposively. We will also use snowball sampling17 
to capture additional insights into planning and imple-
mentation, for instance, alternative perspectives on 
the changes (see table 5 for sampling framework). The 
snowball sampling will use data from the interviews and 
observations.
We will examine implementation and impact of Clin-
ical Working Groups at different stages of development 
and across the different sites by tracking two pathways: 
induction of labour (Women’s and Children’s Care 
CWG) and heart failure (Medicine and Urgent Care 
CWG). These pathways were selected for the following 
reasons: (1) both pathways will involve all sites currently 
included in the hospital group model; (2) one pathway 
has undergone digitisation (induction of labour); (3) 
one pathway represents elective care, whereas the other 
pathway represents emergency care; (4) one pathway is 
more advanced in terms of development. These pathway 
characteristics are important because they will allow us to 
identify the factors that play a role at different stages of 
implementation of the pathways, the ways in which clin-
ical context might shape implementation and the impact 
of technological innovations (ie, digitisation) on stan-
dardisation and the delivery of care. We will also analyse 
the development of the leadership and QI programmes 
and consolidation of clinical and non-clinical services as 
cross-cutting interventions involving multiple sectors of 
the organisations in the group model.
Economic evaluation
For the three areas included in the economic evaluation 
(table 4), the CCA (or CCA framework) will be informed 
by the organisational study. Therefore, no additional 
sampling is required. In turn, interviews are not neces-
sary for the ROI analysis after the scoping stage, although 
this type of analysis requires sufficient longitudinal data, 
which will be requested from the selected CWGs and 
pathways.
data analysis
Implementation study of the group model
Data analysis will be carried out in parallel to data collec-
tion to allow the sharing of interim findings. Iterative 
thematic analysis of interview, observation and documen-
tary data will be conducted, following established proce-
dures of constant comparative analysis.18 Validity will be 
assessed in relation to Patton’s four criteria of validity in 
qualitative research: verification, rival explanations, nega-
tive cases and triangulation.19
Findings from the interviews and observations will be 
triangulated with relevant documents and local metrics 
(eg, metrics established locally to measure group perfor-
mance, metrics on activity and outcomes for the new 
pathways). In terms of implementation, pathway teams 
have been identified within the hospital group’s oper-
ating model as key to getting clinical standards into prac-
tice. By observing teams in action and shadowing pathway 
leads, we would aim to identify lessons on how the imple-
mentation is led in a range of clinical and organisational 
settings. We will also look at the processes used to design 
and deliver standardised clinical practice (considering 
the role of technology as a potential facilitator through 
digitisation). Documents will be analysed to further 
develop an understanding of the programme, the theory 
of improvement and how it changed, and track imple-
mentation of the programme over time.
health economic evaluation
Following data collection and preliminary data anal-
ysis for the organisational study, qualitative findings will 
be used to develop the consequences for the CCA and 
these will mirror the objectives of the programme theory 
(table 2). The final number of consequences is yet to be 
determined. The most suitable consequence measures 
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will be determined jointly and discussed with relevant 
stakeholders, following the principle of co-production. 
The CCA will draw on some of the lessons learnt from 
the qualitative research, effectively producing a mixed-
methods evaluation. Table 6 provides examples of possible 
consequence measures. For three areas of the evaluation, 
a separate CCA will be conducted (table 4).
The ROI data analysis will be carried out at different 
stages, given that it depends on the timing of implemen-
tation. ROI studies for the two selected pathways may 
require some time lag between implementation (and 
associated costs) of the (standardised) pathway and 
cost reductions, as it is expected that some effects will 
take longer to be observed. In order to assess the return 
on investment, data for all investments made and cost 
involved in the two pathways would be required before 
and after the implementation of the model.
Combining the strands of the study
This evaluation is designed to be mixed-methods, in 
which quantitative components and qualitative compo-
nents are jointly analysed to provide a more comprehen-
sive picture. Moreover, the ethos of embedded research 
and the principle of co-production help ensure that a 
formative feedback process enables the quantitative and 
qualitative components of the study to provide a joint 
narrative and substantiate joint findings.
The economic analysis will draw from the qualitative 
multisited ethnography component of the evaluation 
and learning shared throughout the evaluation to define 
and refine the consequences framework in the CCA, as 
well as to provide narrative reasoning for the emerging 
economic findings. Interviews will be used to inform the 
economic evaluation, including the collection of data on 
cost (eg, new staff roles and time allocated by existing 
staff). Although the final CCA will be produced at a later 
stage in the evaluation time frame, interim findings, 
particularly focused on progress and achievement (or 
the lack thereof) in terms of consequences will be shared 
regularly with the hospital group stakeholders. The 
qualitative study will use the interim findings from the 
economic evaluation to collect information that might be 
missing or target areas not originally included in the eval-
uation design. Once the qualitative emerging findings are 
turned into quantifiable consequences, a narrative from 
the ethnographic component of the evaluation will be 
used to explain changes in consequence outcomes.
Patient and public involvement (PPI)
We have set-up and coordinate an evaluation PPI panel 
comprising patient representatives, carer representatives 
and members of the public. Panel members have been 
involved since early stages of study design, providing 
input on the development of research questions, identifi-
cation of areas of the group model to include in the eval-
uation, and the methods of data collection and analysis. 
The panel will be involved throughout the study.
EthICs And dIssEMInAtIon
The study protocol was reviewed by the local R&D office 
and the UCL Ethics Committee and classified as a service 
evaluation, thus not requiring approval by a research 
ethics committee. However, we will conduct this evalua-
tion to the highest ethical standards, following guidelines 
for data security, confidentiality and information gover-
nance. We will follow an informed consent process with 
potential participants for the interviews and observations. 
We will maintain the anonymity of all research partici-
pants. Data will be stored securely and only members of 
the team will have access.
The successful implementation of the evaluation 
will depend on ensuring the researchers have access to 
people, areas and data. The areas covered in the evalua-
tion will depend on their implementation within the study 
time frame. The relationships created and maintained 
with staff throughout the evaluation will be instrumental 
in guaranteeing this access. Another potential challenge 
of embedded research is the loss of impartiality.7 Impor-
tantly, whereas the embedded team will work in close 
partnership with professionals and managers, the team 
will retain critical distance in order for the evaluation 
Table 6 Objectives, possible consequences and measurement scale
Objective Consequence Scale
Standardise processes to reduce 
unwarranted variation
Percentage of standardised pathways Ratio between the number of pathways 
standardised and total number of 
pathways
Use leadership and expertise to drive 
improvement
Increase in leadership training
Increase in uptake of leadership training 
and events
Scale 1–4 for both consequences:
1: No increase
2: Small increase
3: Moderate increase
4: Large increase
Deliver system-wide benefits through 
whole pathway re-design
Reduction in admissions to secondary 
care (gap and ratio)
Out of scope
Greyed out row (on whole pathway design or population health) outside the scope of this evaluation, as it is expected that system-wide 
benefits will take longer to realise than the 30 months of this evaluation. 
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to provide independent findings. Our research team 
has previous experience of working in similar situations 
and has established a series of strategies to address these 
potential tensions between co-production and indepen-
dent research: (1) although one of the researchers is 
embedded, the rest of the research team is based at UCL, 
providing a more distant and critical perspective; (2) the 
UCL team and staff from healthcare organisations will 
agree during initial stages of the project and throughout 
that the UCL team will maintain an independent role 
throughout the evaluation, will share both positive and 
negative feedback to different groups of stakeholders 
within the organisation and will publish the findings.
The team will share feedback on a quarterly basis with 
relevant Boards and other groups across the organisation 
(including patient groups). These dissemination arrange-
ments will be reviewed regularly with stakeholders over 
the course of the study. Formative feedback will include1 
sharing our evolving understanding of the programme 
theory and suggested refinements2; providing ‘real-
time’ insights into implementation of new structures 
(eg, CWGs) that are being used to enable organisational 
change (eg, areas that are being neglected, factors that 
are acting as barriers in implementation and potential 
solutions, and groups that might have been excluded); 
and3 analysing staff views on the process of change.
The evaluation will also generate wider lessons for the 
NHS to support providers planning new organisational 
models, including guidance for potential adopters of new 
models of care on implementing change. Our embedded 
research approach will allow us to be responsive to the 
hospital group’s needs, so we can adapt the frequency 
and format of feedback in line with the organisation’s 
requirements. We will also aim to disseminate the study 
findings through articles published in peer-reviewed jour-
nals and presentations in academic conferences.
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